Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quipt Home Medical (QIPT) EBITDA (2020 - 2025)

Historic EBITDA for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to $11.9 million.

  • Quipt Home Medical's EBITDA rose 2000.81% to $11.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $37.6 million, marking a year-over-year increase of 7639.72%. This contributed to the annual value of $35.6 million for FY2025, which is 1009.72% down from last year.
  • As of Q4 2025, Quipt Home Medical's EBITDA stood at $11.9 million, which was up 2000.81% from $8.9 million recorded in Q3 2025.
  • Quipt Home Medical's 5-year EBITDA high stood at $14.7 million for Q3 2023, and its period low was -$749000.0 during Q1 2023.
  • Over the past 5 years, Quipt Home Medical's median EBITDA value was $6.2 million (recorded in 2022), while the average stood at $5.8 million.
  • Per our database at Business Quant, Quipt Home Medical's EBITDA tumbled by 10793.77% in 2023 and then skyrocketed by 109647.7% in 2025.
  • Quipt Home Medical's EBITDA (Quarter) stood at $3.4 million in 2021, then plummeted by 90.4% to $325000.0 in 2022, then soared by 357.85% to $1.5 million in 2023, then soared by 566.73% to $9.9 million in 2024, then grew by 20.01% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q4 2025, $8.9 million for Q3 2025, and $7.9 million during Q2 2025.